SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $99,000 | -82.0% | 869,122 | +168.6% | 0.00% | – |
| Q3 2018 | $551,000 | +44.2% | 323,540 | +47.1% | 0.00% | – |
| Q2 2018 | $382,000 | -14.9% | 219,900 | -10.3% | 0.00% | – |
| Q1 2018 | $449,000 | -70.2% | 245,200 | -63.8% | 0.00% | – |
| Q4 2017 | $1,508,000 | -91.8% | 676,448 | -89.3% | 0.00% | -100.0% |
| Q3 2017 | $18,302,000 | -33.7% | 6,311,232 | +1.7% | 0.01% | -41.7% |
| Q2 2017 | $27,610,000 | -4.1% | 6,204,669 | +0.4% | 0.02% | -7.7% |
| Q1 2017 | $28,803,000 | +543.5% | 6,180,866 | +740.9% | 0.03% | +550.0% |
| Q4 2016 | $4,476,000 | -57.2% | 735,025 | -61.3% | 0.00% | -60.0% |
| Q3 2016 | $10,465,000 | +62.7% | 1,899,395 | +12.2% | 0.01% | +42.9% |
| Q2 2016 | $6,431,000 | +320.9% | 1,692,437 | +205.9% | 0.01% | +250.0% |
| Q1 2016 | $1,528,000 | -89.2% | 553,350 | -77.8% | 0.00% | -86.7% |
| Q4 2015 | $14,141,000 | -31.8% | 2,493,970 | -36.3% | 0.02% | -25.0% |
| Q3 2015 | $20,748,000 | +325.7% | 3,914,655 | +566.6% | 0.02% | +400.0% |
| Q2 2015 | $4,874,000 | +2075.9% | 587,247 | +1109.0% | 0.00% | – |
| Q1 2015 | $224,000 | +126.3% | 48,573 | +49.4% | 0.00% | – |
| Q4 2014 | $99,000 | +86.8% | 32,505 | +70.6% | 0.00% | – |
| Q3 2014 | $53,000 | +39.5% | 19,058 | +103.0% | 0.00% | – |
| Q2 2014 | $38,000 | -81.6% | 9,388 | -75.8% | 0.00% | – |
| Q1 2014 | $206,000 | – | 38,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|